@FiercePharma: Pharma, FDA still lag in post-marketing safety studies. Getting better, but large % unfinished--or not begun. Yesterday's story | Follow @FiercePharma
@CarlyHFierce: NICE says 'no' to Celgene's Revlimid. Article | Follow @CarlyHFierce
> Regulators in Sweden have questioned why the European Medicines Agency would permit doctors to again use Bayer's Trasylol, which was suspended several years ago. Story
> Indian drugmakers Sun Pharma and Lupin have hit trading highs in India. Story
> Tris Pharma has launched dextroamphetamine sulfate oral solution, the first generic of the ADHD drug ProCentra. Release
> Deborah Dunsire, who just two months ago left Takeda's Millennium, has been tapped as the new CEO at EnVivo Pharmaceuticals. Story
@FierceMedDev: ICYM this week's M&A feature - Blockbusters and bloodlettings: A look at 2013's hot start. Special report | Follow @FierceMedDev
@MarkHFierce: Only a few weeks left to nominate a company for this year's FMD Fierce 15. Submit your nomination | Follow @MarkHFierce
@DamianFierce: Device outfit CVRx has raised $29.6M in a round led by NEA and J&J. Article | Follow @DamianFierce
> Report: Baxter's $4B bid for Gambro to win EU approval. More
> Stentys' self-apposing cardiac stent gains expanded CE mark indications. Item
> VisionCare discloses CMS coverage plan for implantable miniature telescope. Story
> Myriad targets Gene By Gene in second BRCA patent suit. Report
Biotech News
@FierceBiotech: 2013 Biotech IPOs: The biotech IPO scene turns red hot. Special report | Follow @FierceBiotech
@JohnCFierce: Deborah Dunsire makes quick leap from Millennium to fast-growing EnVivo. News | Follow @JohnCFierce
@RyanMFierce: Alnylam Pharma spotlights more upbeat human data or gene-silencing drugs. Story | Follow @RyanMFierce
@EmilyMFierce: Anti-leukemia compound could also treat common breast cancers. Story | Follow @EmilyMFierce
> Rockwell Medical shares spike on positive PhIII data. Item
> EU, pharma industry pledge $4.4B for R&D projects. Story
> Booming China poised to take a top position in global drug R&D. Article
Pharma Manufacturing News
@EricPFierce: BioPlan says China, India losing luster for outsourced biopharmaceutical manufacturing. More | Follow @EricPFierce
> Wockhardt faces 2nd import alert. Report
> Sanofi's ImmuCyst available in next year, Alliance Pharma says. More
> Pfizer to invest $130M in 2 plants in Ireland. News
> Contract manufacturer Piramal also into development, cellphones. Story
Vaccines News
> Manufacturers prepare for resurgence of H7N9. News
> Robot eases kids' vaccination distress in study. More
> Novartis inks typhoid vax licensing deal with Biological E. Story
> U.K. mumps outbreak linked to waning MMR protection. Report
And Finally... AstraZeneca ($AZN) hosted what it labeled the "Inaugural Breast Cancer Blogger Summit," in which it invited a contingent of breast cancer bloggers to its offices in Fairfax, DE, to talk about what it is doing with breast cancer treatments, among other things. Report